Odyssey Health (ODYY) EBIT (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 39.99% |
| Oct 31, 2025 | -94.75% |
| Jul 31, 2025 | -20.63% |
| Apr 30, 2025 | 17.59% |
| Jan 31, 2025 | 72.97% |
| Oct 31, 2024 | -344.04% |
| Jul 31, 2024 | 163.76% |
| Apr 30, 2024 | 67.83% |
| Jan 31, 2024 | -233.32% |
| Oct 31, 2023 | 47.00% |
| Jul 31, 2023 | 40.15% |
| Apr 30, 2023 | 26.36% |
| Jan 31, 2023 | 28.46% |
| Oct 31, 2022 | -13.25% |
| Jul 31, 2022 | 36.00% |
| Apr 30, 2022 | -45.07% |
| Jan 31, 2022 | -38.24% |
| Oct 31, 2021 | 45.18% |
| Jul 31, 2021 | 78.44% |
| Apr 30, 2021 | -1,808.25% |
| Jan 31, 2021 | -20.66% |
| Oct 31, 2020 | 54.58% |
| Jul 31, 2020 | -33.29% |
| Apr 30, 2020 | -73.62% |
| Jan 31, 2020 | 62.22% |
| Oct 31, 2019 | 94.35% |
| Jul 31, 2019 | -51,663.39% |
| Apr 30, 2019 | 49.66% |
| Jan 31, 2019 | -71.29% |
| Oct 31, 2018 | 35.93% |
| Jul 31, 2018 | -42.49% |
| Apr 30, 2018 | 75.23% |
| Jan 31, 2018 | -368.23% |
| Oct 31, 2017 | 7.03% |
| Jul 31, 2017 | 26.46% |
| Apr 30, 2017 | -178.14% |
| Jan 31, 2017 | -63.61% |
| Oct 31, 2016 | 48.72% |
| Jul 31, 2016 | -893.12% |
| Apr 30, 2016 | 78.80% |
| Jan 31, 2016 | 40.30% |
| Oct 31, 2015 | -3.07% |
| Jul 31, 2015 | 43.50% |
| Apr 30, 2015 | 14.34% |
| Jan 31, 2015 | -23.44% |